myocardial fibrosis
Jump to navigation
Jump to search
Etiology
- hypertension
- other heart disease
Comparative biology
- a combination of CAR T-cell therapy & mRNA vaccine used to treat myocardial fibrosis in mice without apparent adverse effects[1]
More general terms
More specific terms
References
- ↑ 1.0 1.1 Rurik JG et al. CAR T cells produced in vivo to treat cardiac injury. Science 2022 Jan 6; 375:91 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34990237 https://www.science.org/doi/10.1126/science.abm0594
Gao TA, Chen YY. T cells to fix a broken heart. Science 2022 Jan 6; 375:23 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34990255